American International Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-65,577
| Closed | -$145K | – | 2769 |
|
|
2024
Q1 | $145K | Sell |
65,577
-563
| -0.9% | -$1.24K | ﹤0.01% | 2320 |
|
|
2023
Q4 | $155K | Sell |
66,140
-267
| -0.4% | -$627 | ﹤0.01% | 2306 |
|
|
2023
Q3 | $124K | Buy |
66,407
+2,361
| +4% | +$4.39K | ﹤0.01% | 2392 |
|
|
2023
Q2 | $168K | Buy |
64,046
+146
| +0.2% | +$383 | ﹤0.01% | 2277 |
|
|
2023
Q1 | $104K | Buy |
63,900
+1,272
| +2% | +$2.07K | ﹤0.01% | 2433 |
|
|
2022
Q4 | $83.3K | Sell |
62,628
-228
| -0.4% | -$303 | ﹤0.01% | 2592 |
|
|
2022
Q3 | $98K | Buy |
62,856
+888
| +1% | +$1.38K | ﹤0.01% | 2570 |
|
|
2022
Q2 | $95K | Buy |
+61,968
| New | +$95K | ﹤0.01% | 2633 |
|
|
2021
Q2 | – | Sell |
-26,788
| Closed | -$121 | – | 3288 |
|
|
2021
Q1 | $121 | Buy |
26,788
+71
| +0.3% | – | ﹤0.01% | 2618 |
|
|
2020
Q4 | $131 | Sell |
26,717
-767
| -3% | -$4 | ﹤0.01% | 2517 |
|
|
2020
Q3 | $163K | Buy |
27,484
+4,653
| +20% | +$27.6K | ﹤0.01% | 2264 |
|
|
2020
Q2 | $61K | Buy |
22,831
+1,741
| +8% | +$4.65K | ﹤0.01% | 2809 |
|
|
2020
Q1 | $41K | Buy |
21,090
+4,394
| +26% | +$8.54K | ﹤0.01% | 2763 |
|
|
2019
Q4 | $118K | Sell |
16,696
-142
| -0.8% | -$1K | ﹤0.01% | 2528 |
|
|
2019
Q3 | $166K | Sell |
16,838
-116
| -0.7% | -$1.14K | ﹤0.01% | 2298 |
|
|
2019
Q2 | $194K | Buy |
16,954
+3,896
| +30% | +$44.6K | ﹤0.01% | 2252 |
|
|
2019
Q1 | $131K | Buy |
13,058
+8,655
| +197% | +$86.8K | ﹤0.01% | 2465 |
|
|
2018
Q4 | $75K | Buy |
4,403
+13
| +0.3% | +$221 | ﹤0.01% | 2734 |
|
|
2018
Q3 | $77K | Buy |
+4,390
| New | +$77K | ﹤0.01% | 2946 |
|